EUVIMEDEUVIMED entdecken
Open Access

Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer

Min Wu, Jiuqing Xie, Yajing Xing, Lin Zhang, Huang Chen, Bin Tang, Miaoran Zhou, Shiyi Lv, Dongxia Huang, Shuyi Jian, Cili Zhou, Mingyao Liu und 3 weitere

International Journal of Biological Sciences · 2024 · 20 (2) · 486-501

DOI: 10.7150/ijbs.86303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Min Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: East China Normal University, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, 500 Dong C…. Hauptthemen laut MEDLINE: Cisplatin, Ovarian Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinOvarian NeoplasmsHumansFemaleAnimalsMiceProto-Oncogene Proteins c-bcl-6Transcription FactorsCell Line, Tumor

Stichwörter der Autor:innen

BCL6BTB domainMetastasisOvarian cancer

Substanzen

CisplatinProto-Oncogene Proteins c-bcl-6Transcription FactorsBCL6 protein, human

Autor:innen und Institutionen

  • East China Normal University, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, 500 Dong Chuan Rd, Shanghai 200241, China.
  • Department of Gynecology, The Second People's Hospital of Wuhu, Wuhu, Anhui 241000, China.
  • Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • The Jointed National Laboratory of Antibody Drug Engineering, Henan University, Kaifeng, 475004, China.

Zitieren

APA

Wu, M., Xie, J., Xing, Y., Zhang, L., Chen, H., Tang, B., Zhou, M., Lv, S., Huang, D., Jian, S., Zhou, C., Liu, M., Guo, W., Chen, Y., & Yi, Z. (2024). Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer. International Journal of Biological Sciences, 20(2), 486-501. https://doi.org/10.7150/ijbs.86303

Vancouver

Wu M, Xie J, Xing Y, Zhang L, Chen H, Tang B, et al. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer. International Journal of Biological Sciences. 2024;20(2):486-501. doi:10.7150/ijbs.86303

BibTeX
@article{Wu2024,
  author = {Wu, Min and Xie, Jiuqing and Xing, Yajing and Zhang, Lin and Chen, Huang and Tang, Bin and Zhou, Miaoran and Lv, Shiyi and Huang, Dongxia and Jian, Shuyi and Zhou, Cili and Liu, Mingyao and Guo, Weikai and Chen, Yihua and Yi, Zhengfang},
  title = {Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {2},
  pages = {486--501},
  doi = {10.7150/ijbs.86303}
}
Kostenlos starten →